116
Views
0
CrossRef citations to date
0
Altmetric
Original Articles

Wickerhamomyces Anomalus Postoperative Endophthalmitis

, MD, , MD & , MD
Pages 1519-1521 | Received 14 Feb 2022, Accepted 10 Aug 2022, Published online: 27 Sep 2022

References

  • Vilela RC, Vilela L, Vilela P, et al. Etiological agents of fungal endophthalmitis: diagnosis and management. Int Ophthalmol. 2014 Jun;34(3):707–721. doi:10.1007/s10792-013-9854-z.
  • Wykoff CC, Flynn HW Jr, Miller D, Scott IU, Alfonso EC. Exogenous fungal endophthalmitis: microbiology and clinical outcomes. Ophthalmology. 2008 Sep;115(9):1501–1502. doi:10.1016/j.ophtha.2008.02.027.
  • Durand ML. Bacterial and fungal endophthalmitis. Clin Microbiol Rev. 2017;30(3):597–613. doi:10.1128/CMR.00113-16.
  • Mínguez E, Ángeles M, Buey D, Cristóbal JÁ. Capítulo 159 - Tratamiento de la endoftalmitis en cirugía de la catarata. In: Lorente R, Mendicute J, eds. Cirugía del Cristalino. Sociedad Española de Oftalmología. 2008.
  • Smith TC, Benefield RJ, Kim JH. Risk of fungal endophthalmitis associated with cataract surgery: a mini-review. Mycopathologia. 2015;180(5–6):291–297. doi:10.1007/s11046-015-9932-z.
  • Kurtzman CP. Phylogeny of the ascomycetous yeasts and the renaming of Pichia anomala to Wickerhamomyces anomalus. Antonie Van Leeuwenhoek. 2011 Jan;99(1):13–23. doi:10.1007/s10482-010-9505-6.
  • Fernández-Ruiz M, Guinea J, Puig-Asensio M, et al. CANDIPOP project; GEIH-GEMICOMED (SEIMC) and REIPI. Fungemia due to rare opportunistic yeasts: data from a population-based surveillance in Spain. Med Mycol. 2017 Feb 1;55(2):125–136. doi:10.1093/mmy/myw055.
  • Zhang L, Xiao M, Arastehfar A, et al. Investigation of the emerging nosocomial Wickerhamomyces anomalus infections at a Chinese Tertiary Teaching Hospital and a systemic review: clinical manifestations, risk factors, treatment, outcomes, and anti-fungal susceptibility. Front Microbiol. 2021 Oct 6;12:744502. doi:10.3389/fmicb.2021.744502.
  • Jung J, Moon YS, Yoo JA, Lim J-H, Jeong J, Jun J-B. Investigation of a nosocomial outbreak of fungemia caused by Candida pelliculosa (Pichia anomala) in a Korean tertiary care center. J Microbiol Immunol Infect [Internet]. 2018;51(6):794–801. doi:10.1016/j.jmii.2017.05.005.
  • da Silva CM, de Carvalho Parahym AMR, Leão MPC, de Oliveira NT, de Jesus Machado Amorim R, Neves RP. Fungemia by Candida pelliculosa (Pichia anomala) in a neonatal intensive care unit: a possible clonal origin. Mycopathologia. 2013;175(1–2):175–179. doi:10.1007/s11046-012-9605-0.
  • Kamoshita M, Matsumoto Y, Nishimura K, et al. Wickerhamomyces anomalus fungal keratitis responds to topical treatment with antifungal micafungin. J Infect Chemother [Internet]. 2015;21(2):141–143. doi:10.1016/j.jiac.2014.08.019.
  • Park KA, Ahn K, Chung ES, Chung TY. Pichia anomala fungal keratitis. Cornea. 2008;27(5):619–620. doi:10.1097/ICO.0b013e318166c442.
  • Esgin H, Bulut E, Örüm Ç. Candida pelliculosa endophthalmitis after cataract surgery: a case report. BMC Res Notes. 2014;7(1):7–9. doi:10.1186/1756-0500-7-169.
  • Kurtzman CP. Chapter 80 - Wickerhamomyces. In: Kurtzman CP, Fell JW, Boekhout T, eds. The Yeasts. 5th ed. Elsevier; 2011:899–917.
  • Stavrou AA, Pérez-Hansen A, Lackner M, Lass-Flörl C, Boekhout T. Elevated minimum inhibitory concentrations to antifungal drugs prevail in 14 rare species of candidemia-causing Saccharomycotina yeasts. Med Mycol. 2020 Oct 1;58(7):987–995. doi:10.1093/mmy/myaa005.
  • Hariprasad SM, Mieler WF, Holz ER, et al. Determination of vitreous, aqueous, and plasma concentration of orally administered voriconazole in humans. Arch Ophthalmol. 2004;122(1):42–47. doi:10.1001/archopht.122.1.42.
  • Kim DY, Moon HI, Joe SG, Kim JG, Yoon YH, Lee JY. Recent clinical manifestation and prognosis of fungal endophthalmitis: a 7-year experience at a tertiary referral center in Korea. J Korean Med Sci. 2015 Jul;30(7):960–964. doi:10.3346/jkms.2015.30.7.960.
  • Sen S, Lalitha P, Mishra C, et al. Post-cataract surgery fungal endophthalmitis: management outcomes and prognostic factors. Ocul Immunol Inflamm. 2021 Nov 17;29(7–8):1530–1536. doi:10.1080/09273948.2020.1737143.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.